Navigating Paragraph IV Challenges, the Biologic Super-Cliff, and AI-Driven IP Valorization
The global pharmaceutical industry in 2026 exists in a state of hyper-dynamic transition, defined by the convergence of the most […]
The global pharmaceutical industry in 2026 exists in a state of hyper-dynamic transition, defined by the convergence of the most […]
Pharmaceutical procurement teams spend enormous effort negotiating the price on a purchase order. Then they lose more money in the
Cut Pharma Procurement Costs by 25%: The Total Cost of Ownership Playbook Read Post »
Switzerland generates more patent applications per capita than any other country on earth. In 2024, the European Patent Office received
We’re excited to announce that DrugPatentWatch is now available on the Snowflake Marketplace, making it easier than ever for organizations
DrugPatentWatch Now Available on the Snowflake Marketplace Read Post »
The global pharmaceutical sector is undergoing a massive redistribution of capital. Between 2025 and 2030, an estimated $236 billion to
Buying Smart: The No-Nonsense Guide to Pharma Procurement Read Post »
Why Parallel Proceedings Matter More Than Ever Pharmaceutical patent litigation has always been expensive and slow. What changed after the
Part I: The Generic Drug Market in Numbers Global Market Size and Growth Projections The global generic drugs market was
The Thicket Defined: What You’re Actually Fighting A biologic patent thicket is not a portfolio. It is a deliberate system
Biologic Patent Thickets: How They Work, Why They’re Losing, and What Comes Next Read Post »
Executive Summary The pharmaceutical industry runs on a contradiction that has defined the last 25 years. The science has never
Get fresh news and insights, drug patent expirations & more…